OY3 (PYP-TC99M atrial amyloidosis) cannot be located on the price schedule found that this item was inadvertently left off the price list
Active Awarded Last action
- Contract number
- 36C25026N0185
- Awardee
-
Schaaf Drugs, LLC UEI LSEHGNVLAVX5
- Awarding agency
-
Veterans Integrated Service Network 10
Veterans Health Administration, Department of Veterans Affairs
- Obligated
- $118,668
Award facts
- Contract value 20% obligated
-
- $351,307.30 Current, with exercised options
- $604,961.69 Potential, with all options
- Completion date 76% complete
-
- Current, with exercised options
- Potential, with all options
- Contracting staff
- NAICS code
- 325412 Pharmaceutical Preparation Manufacturing
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition after exclusion of sources Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Lima, OH 45801, USA
Award details come from SAM.gov/FPDS.
About this award
Schaaf Drugs, LLC, doing business as Heartlight Pharmacy Services, was awarded a delivery order valued at $604,961.69 by the Department of Veterans Affairs (VA), Veterans Integrated Service Network 10 (VISN 10), for radiopharmaceutical drugs and related nuclear medicine services. The contract is a firm fixed-price delivery order with an ultimate completion date of January 5, 2028, and will be performed in Lima, Ohio. This award does not utilize a set-aside designation. The delivery order addresses an administrative gap, as the specific item OY3 (PYP-TC99M Atrial Amyloidosis)—a diagnostic radiopharmaceutical used in cardiac imaging—was inadvertently omitted from the original price schedule and is now being procured through this mechanism.
Schaaf Drugs has established itself as a specialized supplier of radiopharmaceutical products to the VA's VISN 10 region, which encompasses Ohio and Indiana. The company holds multiple indefinite delivery contracts with the VA for radiopharmaceutical drugs and radioactive isotopes, with potential values ranging from approximately $340,000 to $3.9 million. These contracts enable the VA to order critical diagnostic and therapeutic nuclear medicine supplies, including Technetium-99m derivatives and other specialized medical isotopes essential for veterans' healthcare imaging and treatment programs. This delivery order represents another instance of the VA's continued reliance on Schaaf Drugs' specialized pharmaceutical expertise to support nuclear medicine services across the VISN 10 network.
Quick answers
Who was awarded contract 36C25026N0185?
36C25026N0185 was awarded to Schaaf Drugs, LLC by Veterans Integrated Service Network 10 (Veterans Health Administration) on January 6, 2023.
How much is contract 36C25026N0185 worth?
The government has obligated $118,668 on 36C25026N0185. Its current value, with exercised options, is $351,307. Its potential value, with all options, is $604,962.
Is contract 36C25026N0185 an order under another contract?
Yes. 36C25026N0185 is a delivery order under 36C25023D0023, an indefinite delivery contract.
Was contract 36C25026N0185 competed?
The extent of competition for 36C25026N0185 was full and open competition after exclusion of sources.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award